The ABCG2 Transporter Affects Plasma Levels, Tissue Distribution and Milk Secretion of Lumichrome, a Natural Derivative of Riboflavin.

Autor: Millán-García, Alicia¹ (AUTHOR) amilg@unileon.es, Álvarez-Fernández, Laura¹ (AUTHOR), Blanco-Paniagua, Esther¹ (AUTHOR), Álvarez, Ana I.¹ (AUTHOR), Merino, Gracia¹ (AUTHOR) gmerp@unileon.es

Publikováno v: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 18, p9884. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

ABCG2 transporter reduces protein aggregation in cigarette smoke condensate-exposed A549 lung cancer cells.

Autor: Ajenu, Emmanuella O.¹ (AUTHOR), Seideneck, Ashley M.¹ (AUTHOR), Pandellapalli, Esh¹ (AUTHOR), Shinsky, Emily M.¹ (AUTHOR), Humphries, Casey L.¹ (AUTHOR), Aparicio, Nicholas L.¹ (AUTHOR), Sharma, Mahak¹ (AUTHOR), Marden, James H.² (AUTHOR), Krasilnikova, Maria M.¹ (AUTHOR) muk19@psu.edu

Publikováno v: PLoS ONE. 3/5/2024, Vol. 19 Issue 3, p1-15. 15p.

Targeting ABCG2 transporter to enhance 5-aminolevulinic acid for tumor visualization and photodynamic therapy

Autor: Chandratre, Sharayu, Olsen, Jordyn, Howley, Richard, Chen, Bin

Publikováno v: In Biochemical Pharmacology November 2023 217

Roles of the ABCG2 Transporter in Protoporphyrin IX Distribution and Toxicity.

Autor: Qi Q; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania (Q.Q., R.G., J.Z., X.M.) and Porphyria Laboratory and Center, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas (K.E.A.)., Gu R; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania (Q.Q., R.G., J.Z., X.M.) and Porphyria Laboratory and Center, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas (K.E.A.)., Zhu J; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania (Q.Q., R.G., J.Z., X.M.) and Porphyria Laboratory and Center, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas (K.E.A.)., Anderson KE; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania (Q.Q., R.G., J.Z., X.M.) and Porphyria Laboratory and Center, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas (K.E.A.)., Ma X; Center for Pharmacogenetics, Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania (Q.Q., R.G., J.Z., X.M.) and Porphyria Laboratory and Center, Division of Gastroenterology and Hepatology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas (K.E.A.) mxiaocha@pitt.edu.

Publikováno v: Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2024 Oct 16; Vol. 52 (11), pp. 1201-1207. Date of Electronic Publication: 2024 Oct 16.